High-Dose Chemotherapy for Desmoplastic Small Round-Cell Tumor
Author Information
Author(s): Bertuzzi A, Castagna L, Quagliuolo V, Ginanni V, Compasso S, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Sarina B, Parra H Soto, Santoro A
Primary Institution: Istituto Clinico Humanitas
Hypothesis
Does high-dose chemotherapy improve outcomes in adult patients with desmoplastic small round-cell tumor?
Conclusion
High-dose chemotherapy does not improve clinical outcomes in patients with desmoplastic small round-cell tumor.
Supporting Evidence
- 50% of patients achieved partial response after induction chemotherapy.
- 60% of patients proceeded to surgery after treatment.
- The median overall survival was 14 months.
Takeaway
This study looked at whether stronger chemotherapy helps people with a rare cancer called desmoplastic small round-cell tumor, and it found that it doesn't really help.
Methodology
Patients aged 15-60 with desmoplastic small round-cell tumor were treated with high-dose chemotherapy and autologous stem cell transplantation, followed by response evaluation.
Limitations
The study had a small sample size and focused only on male patients.
Participant Demographics
All 10 patients were male with a median age of 29 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website